Stock Analysis on Net
Stock Analysis on Net

Analysis of Short-term (Operating) Activity Ratios 
Quarterly Data

Microsoft Excel

Short-term Activity Ratios (Summary)

Medtronic PLC, short-term (operating) activity ratios (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Turnover Ratios
Inventory turnover 2.11 2.14 1.98 1.95 2.02 2.12 2.06 2.11 2.10 2.15 1.95 1.92 1.91 2.03 1.92 2.00 2.09 2.20 2.26 2.38 2.47
Receivables turnover 5.91 5.47 5.58 5.44 5.46 5.15 5.43 5.27 5.42 5.28 5.42 5.39 5.44 5.21 5.23 5.48 5.85 5.71 5.84 5.79 5.82
Payables turnover 4.87 4.81 4.85 4.64 4.65 4.75 5.04 4.85 4.95 4.65 5.60 5.09 4.84 4.03 4.68 4.60 4.62 4.46 5.14 5.41 5.67
Working capital turnover 2.98 2.77 2.43 2.47 2.92 3.07 3.11 3.22 2.79 2.90 2.54 2.57 2.46 2.47 2.81 2.82 3.84 2.97 2.21 2.13 2.15
Average No. Days
Average inventory processing period 173 171 185 187 181 172 178 173 174 170 187 190 191 180 190 183 174 166 161 153 148
Add: Average receivable collection period 62 67 65 67 67 71 67 69 67 69 67 68 67 70 70 67 62 64 63 63 63
Operating cycle 235 238 250 254 248 243 245 242 241 239 254 258 258 250 260 250 236 230 224 216 211
Less: Average payables payment period 75 76 75 79 79 77 72 75 74 78 65 72 75 91 78 79 79 82 71 67 64
Cash conversion cycle 160 162 175 175 169 166 173 167 167 161 189 186 183 159 182 171 157 148 153 149 147

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).


An analysis of short-term activity ratios reveals a period of expanding operational cycles followed by a phase of relative stabilization. The primary driver of volatility throughout the observed timeframe was inventory management, while receivables remained consistently stable, and payables experienced strategic fluctuations.

Inventory Management Efficiency
A downward trend in inventory turnover is observed from July 2021 (2.47) reaching a trough in July 2023 (1.91). This decline is mirrored by the average inventory processing period, which extended from 148 days to a peak of 191 days. From late 2023 through July 2026, a moderate recovery occurred, with the turnover ratio stabilizing around 2.11 and the processing period normalizing to 173 days.
Receivables and Collections
Receivables turnover remained remarkably stable throughout the period, fluctuating within a narrow range between 5.21 and 5.91. Consequently, the average receivable collection period showed minimal variance, generally oscillating between 62 and 71 days. This indicates a highly consistent and disciplined approach to credit management and collections.
Payables and Liquidity Strategy
Payables turnover showed more volatility, declining from 5.67 in July 2021 to a low of 4.03 in April 2023, before recovering to 4.87 by July 2026. The average payables payment period expanded from 64 days to a maximum of 91 days in April 2023, suggesting a temporary extension of payment terms to suppliers to preserve cash flow, followed by a return to a more stable payment cycle of approximately 75 days.
Operational Cycle and Cash Conversion
The operating cycle experienced a significant expansion, rising from 211 days in July 2021 to a peak of 260 days in January 2023, primarily driven by the slowing of inventory turnover. The cash conversion cycle followed a similar trajectory, increasing from 147 days to 189 days by January 2024. In the final quarters of the analysis, the cash conversion cycle contracted to 160 days, indicating improved efficiency in converting resources into cash.
Working Capital Utilization
Working capital turnover demonstrated an overall upward trend, increasing from 2.15 in July 2021 to 2.98 in July 2026. Despite some volatility in 2022, the general increase suggests an improved ability to generate revenue relative to the investment in net working capital.

AI Ask an analyst for more


Turnover Ratios


Average No. Days


Inventory Turnover

Medtronic PLC, inventory turnover calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets 3,416 3,398 3,261 3,061 3,001 3,146 2,779 2,946 2,761 3,045 2,782 2,761 2,628 2,979 2,689 2,535 2,516 2,591 2,459 2,497 2,598
Inventories 6,215 5,951 6,309 6,156 5,886 5,476 5,610 5,479 5,414 5,217 5,726 5,754 5,668 5,293 5,375 5,055 4,809 4,616 4,514 4,349 4,288
Short-term Activity Ratio
Inventory turnover1 2.11 2.14 1.98 1.95 2.02 2.12 2.06 2.11 2.10 2.15 1.95 1.92 1.91 2.03 1.92 2.00 2.09 2.20 2.26 2.38 2.47
Benchmarks
Inventory Turnover, Competitors2
Abbott Laboratories 2.76 2.82 2.98 2.88 2.73 2.82 3.02 2.69 2.67 2.65 2.74 2.71 2.62 2.77 3.10 3.37 3.24 3.36
Intuitive Surgical Inc. 1.81 1.83 1.86 1.81 1.83 1.85 1.83 1.75 1.81 1.89 1.96 1.99 2.21 2.25 2.27 2.36 2.62 2.82

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Inventory turnover = (Cost of products sold, excluding amortization of intangible assetsQ1 2027 + Cost of products sold, excluding amortization of intangible assetsQ4 2026 + Cost of products sold, excluding amortization of intangible assetsQ3 2026 + Cost of products sold, excluding amortization of intangible assetsQ2 2026) ÷ Inventories
= (3,416 + 3,398 + 3,261 + 3,061) ÷ 6,215 = 2.11

2 Click competitor name to see calculations.


A long-term decline in inventory turnover efficiency is observed from July 2021 through July 2026. While the cost of products sold exhibited a general upward trajectory, the growth in inventory levels occurred at a pace that outstripped the growth of costs for a significant portion of the observed period, resulting in a lower overall turnover ratio.

Inventory Turnover Trends
The turnover ratio experienced a steady contraction from a peak of 2.47 in July 2021 to a low of 1.91 in July 2023. This downward trajectory indicates a slowing of inventory movement relative to the cost of goods sold during the first two years of the period.
Relationship Between Cost of Products Sold and Inventory Levels
Cost of products sold increased from 2,598 million USD in July 2021 to 3,416 million USD by July 2026. Concurrently, inventory levels rose from 4,288 million USD to 6,215 million USD. The disproportionate increase in inventory holdings between 2021 and 2023 acted as the primary driver for the reduction in the turnover ratio.
Period of Stabilization
From January 2024 through July 2026, the inventory turnover ratio entered a phase of relative stabilization, fluctuating within a range between 1.95 and 2.15. This suggests a shift toward more consistent inventory management after the initial period of efficiency loss.

AI Ask an analyst for more


Receivables Turnover

Medtronic PLC, receivables turnover calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data (US$ in millions)
Net sales 9,756 9,808 9,017 8,961 8,578 8,927 8,292 8,403 7,915 8,589 8,089 7,984 7,702 8,544 7,727 7,585 7,371 8,089 7,763 7,847 7,987
Accounts receivable, less allowances and credit losses 6,357 6,643 6,359 6,389 6,263 6,515 6,115 6,260 6,011 6,128 5,968 5,934 5,806 5,998 5,887 5,626 5,308 5,551 5,446 5,493 5,431
Short-term Activity Ratio
Receivables turnover1 5.91 5.47 5.58 5.44 5.46 5.15 5.43 5.27 5.42 5.28 5.42 5.39 5.44 5.21 5.23 5.48 5.85 5.71 5.84 5.79 5.82
Benchmarks
Receivables Turnover, Competitors2
Abbott Laboratories 5.42 5.50 5.59 5.39 5.41 5.78 6.06 5.85 5.94 6.11 6.11 6.15 6.52 6.89 7.02 7.03 6.33 6.20
Elevance Health Inc. 14.99 14.30 16.34 16.80 14.83 14.42 18.00 19.84 17.60 15.98 18.08 17.93 18.82 16.53 18.81 19.51 18.80 16.67
Intuitive Surgical Inc. 6.59 6.63 6.59 7.63 7.21 7.13 6.82 6.82 6.83 6.49 6.30 7.12 7.37 6.95 6.60 7.20 7.11 6.52
UnitedHealth Group Inc. 20.67 16.76 19.27 18.98 17.29 15.03 17.66 19.43 16.49 13.80 17.27 17.23 19.23 14.88 18.22 18.37 16.27 15.65

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Receivables turnover = (Net salesQ1 2027 + Net salesQ4 2026 + Net salesQ3 2026 + Net salesQ2 2026) ÷ Accounts receivable, less allowances and credit losses
= (9,756 + 9,808 + 9,017 + 8,961) ÷ 6,357 = 5.91

2 Click competitor name to see calculations.


The financial trajectory from July 2021 through July 2026 is characterized by steady growth in top-line revenue and a corresponding increase in outstanding receivables, resulting in a receivables turnover ratio that remained largely resilient despite a period of moderate volatility.

Revenue and Receivables Growth
Net sales exhibited a general upward trend, rising from 7,987 million US dollars in July 2021 to 9,756 million US dollars by July 2026. In parallel, accounts receivable, less allowances and credit losses, increased from 5,431 million US dollars to 6,357 million US dollars. The expansion of receivables suggests that credit extension grew in alignment with the broader growth in sales volume.
Analysis of Receivables Turnover Trends
The receivables turnover ratio experienced three distinct phases. From July 2021 to July 2022, the ratio remained stable, fluctuating within a narrow band between 5.71 and 5.85. A subsequent decline was observed between October 2022 and April 2023, with the ratio reaching a period low of 5.21. This downward movement indicates a temporary reduction in collection efficiency relative to sales growth during that interval.
Stabilization and Recovery
Following the low point in early 2023, the turnover ratio entered a period of stabilization between July 2023 and January 2025, generally oscillating between 5.15 and 5.46. A notable recovery is evident in the final quarters of the analysis, culminating in a ratio of 5.91 by July 2026. This peak represents the highest level of turnover efficiency in the observed period, suggesting a successful optimization of credit collections or a shift toward more favorable customer payment terms.

AI Ask an analyst for more


Payables Turnover

Medtronic PLC, payables turnover calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data (US$ in millions)
Cost of products sold, excluding amortization of intangible assets 3,416 3,398 3,261 3,061 3,001 3,146 2,779 2,946 2,761 3,045 2,782 2,761 2,628 2,979 2,689 2,535 2,516 2,591 2,459 2,497 2,598
Accounts payable 2,695 2,644 2,569 2,581 2,555 2,449 2,286 2,376 2,291 2,410 1,992 2,174 2,239 2,662 2,209 2,198 2,180 2,276 1,985 1,917 1,864
Short-term Activity Ratio
Payables turnover1 4.87 4.81 4.85 4.64 4.65 4.75 5.04 4.85 4.95 4.65 5.60 5.09 4.84 4.03 4.68 4.60 4.62 4.46 5.14 5.41 5.67
Benchmarks
Payables Turnover, Competitors2
Abbott Laboratories 4.22 4.22 4.56 4.69 4.40 4.44 4.46 4.54 4.42 4.33 4.19 4.55 4.28 4.44 4.15 4.67 4.25 4.02
Elevance Health Inc. 8.06 8.06 8.68 8.38 8.07 7.87 8.10 8.17 8.09 7.54 7.72 7.61 7.54 7.57 7.47 7.48 7.35 7.28
Intuitive Surgical Inc. 13.26 10.71 13.42 11.10 11.44 10.39 14.05 11.88 12.91 12.64 12.69 11.66 11.10 12.99 13.78 12.01 12.68 14.36
UnitedHealth Group Inc. 7.98 7.92 7.98 7.44 7.42 7.32 7.72 7.64 7.77 7.28 7.47 7.11 7.08 6.86 7.26 7.07 6.90 6.78

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Payables turnover = (Cost of products sold, excluding amortization of intangible assetsQ1 2027 + Cost of products sold, excluding amortization of intangible assetsQ4 2026 + Cost of products sold, excluding amortization of intangible assetsQ3 2026 + Cost of products sold, excluding amortization of intangible assetsQ2 2026) ÷ Accounts payable
= (3,416 + 3,398 + 3,261 + 3,061) ÷ 2,695 = 4.87

2 Click competitor name to see calculations.


Analysis of short-term operating activity reveals a general expansion in both the cost of products sold and the balance of accounts payable over the observed period. The cost of products sold increased from 2,598 million US dollars in July 2021 to 3,416 million US dollars by July 2026. Parallel to this, accounts payable rose from 1,864 million US dollars to 2,695 million US dollars, reflecting an increase in the absolute volume of obligations to suppliers as operational scale grew.

Payables Turnover Trajectory
The payables turnover ratio exhibited a notable downward trend during the initial phase of the period, falling from a high of 5.67 in July 2021 to a minimum of 4.03 in April 2023. This decline indicates a deceleration in the frequency with which supplier obligations were settled, effectively extending the average payment period.
Ratio Stabilization and Normalization
Following the low point in early 2023, the turnover ratio entered a period of relative stability. From July 2023 through July 2026, the ratio consistently fluctuated between 4.64 and 5.60, ending the period at 4.87. This stabilization suggests the establishment of a consistent credit management strategy and a normalized relationship between procurement costs and payment cycles.
Operational Scale and Working Capital Management
While the cost of products sold grew substantially over the five-year period, the payables turnover ratio did not revert to the higher levels observed in 2021. This suggests a strategic decision to maintain higher levels of accounts payable relative to the cost of sales, which can serve to optimize cash flow by utilizing supplier credit to support increased operational activity.

AI Ask an analyst for more


Working Capital Turnover

Medtronic PLC, working capital turnover calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data (US$ in millions)
Current assets 24,390 24,787 24,071 23,996 23,223 23,814 22,513 22,438 21,947 21,935 22,513 22,081 21,869 21,675 25,364 25,398 22,135 23,059 23,303 22,731 22,434
Less: Current liabilities 11,799 11,658 9,495 9,935 11,530 12,879 11,840 12,195 10,287 10,789 9,793 9,659 9,047 9,051 14,422 14,465 14,049 12,394 8,927 7,803 7,764
Working capital 12,591 13,129 14,576 14,061 11,693 10,935 10,673 10,243 11,660 11,146 12,720 12,422 12,822 12,624 10,942 10,933 8,086 10,665 14,376 14,928 14,670
 
Net sales 9,756 9,808 9,017 8,961 8,578 8,927 8,292 8,403 7,915 8,589 8,089 7,984 7,702 8,544 7,727 7,585 7,371 8,089 7,763 7,847 7,987
Short-term Activity Ratio
Working capital turnover1 2.98 2.77 2.43 2.47 2.92 3.07 3.11 3.22 2.79 2.90 2.54 2.57 2.46 2.47 2.81 2.82 3.84 2.97 2.21 2.13 2.15
Benchmarks
Working Capital Turnover, Competitors2
Abbott Laboratories 6.95 6.33 4.67 4.27 3.91 4.17 4.42 4.63 4.35 4.83 4.54 4.15 4.39 4.21 4.48 3.92 3.63 4.13
Elevance Health Inc. 7.19 7.59 7.50 7.00 7.96 8.11 7.85 6.87 6.92 8.59 7.83 7.92 7.69 7.60 8.37 9.11 8.85 8.65
Intuitive Surgical Inc. 1.45 1.53 1.29 1.43 1.30 1.42 1.56 1.42 1.23 1.17 1.14 0.95 1.03 1.15 1.29 1.21 1.17 1.26
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Working capital turnover = (Net salesQ1 2027 + Net salesQ4 2026 + Net salesQ3 2026 + Net salesQ2 2026) ÷ Working capital
= (9,756 + 9,808 + 9,017 + 8,961) ÷ 12,591 = 2.98

2 Click competitor name to see calculations.


The analysis of working capital turnover reveals a period of significant fluctuation followed by a phase of relative stabilization. While net sales have demonstrated a gradual and consistent upward trajectory over the analyzed period, the efficiency of working capital utilization has been primarily driven by variances in the working capital base rather than sales growth alone.

Working Capital Turnover Volatility
A notable peak in efficiency occurred in July 2022, where the turnover ratio reached 3.84. This surge was primarily attributed to a sharp contraction in working capital, which fell to its lowest point of $8,086 million. Following this peak, the ratio corrected and generally remained between 2.40 and 3.22 through the subsequent quarters.
Revenue Growth Dynamics
Net sales exhibited a steady increase, rising from $7,987 million in July 2021 to a peak of $9,808 million in April 2026. This sustained growth suggests a strengthening top-line performance, although the impact on the turnover ratio was often moderated by simultaneous increases in the working capital requirements.
Working Capital Trends
The working capital balance showed a cyclical pattern, starting at $14,670 million, dipping significantly in mid-2022, and recovering to a peak of $14,576 million by January 2026. The recent decline to $12,591 million by July 2026, coupled with maintained high sales levels, resulted in a turnover ratio of 2.98, indicating a return to higher operational efficiency.
Efficiency Correlation
An inverse relationship is observed between the total working capital held and the turnover ratio. The most efficient periods of operation coincide with lean working capital levels, whereas periods of capital accumulation, such as the trend observed between October 2024 and January 2026, saw the turnover ratio decline toward 2.43.

AI Ask an analyst for more


Average Inventory Processing Period

Medtronic PLC, average inventory processing period calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data
Inventory turnover 2.11 2.14 1.98 1.95 2.02 2.12 2.06 2.11 2.10 2.15 1.95 1.92 1.91 2.03 1.92 2.00 2.09 2.20 2.26 2.38 2.47
Short-term Activity Ratio (no. days)
Average inventory processing period1 173 171 185 187 181 172 178 173 174 170 187 190 191 180 190 183 174 166 161 153 148
Benchmarks (no. days)
Average Inventory Processing Period, Competitors2
Abbott Laboratories 132 129 123 127 134 130 121 136 136 138 133 135 139 132 118 108 113 109
Intuitive Surgical Inc. 201 199 196 201 199 198 200 208 201 193 186 183 166 162 161 155 139 130

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 2.11 = 173

2 Click competitor name to see calculations.


The analysis of short-term operating activity reveals a distinct two-phase trend in inventory management efficiency from July 2021 through July 2026. An initial period of declining efficiency is followed by a phase of relative stabilization and moderate recovery.

Inventory Turnover Dynamics
A consistent decline in the inventory turnover ratio is observed between July 2021 and January 2023, during which the ratio fell from 2.47 to 1.92. Following this decline, the ratio entered a period of fluctuation with a moderate recovery, reaching a localized peak of 2.15 in January 2024. Through 2025 and 2026, the turnover ratio remained relatively stable, oscillating within a range of 1.95 to 2.14.
Average Inventory Processing Period
The timeframe required to process inventory experienced a steady expansion from 148 days in July 2021 to a peak of 191 days in July 2023. This expansion indicates a slowdown in inventory movement. A corrective shift occurred in early 2024, where the processing period dropped to 170 days. For the remainder of the analyzed period ending July 2026, the processing period remained range-bound, fluctuating between 171 and 187 days.
Operational Efficiency Correlation
A strong inverse correlation is evident between the turnover ratio and the processing period. The peak in processing days in July 2023 corresponds with the lowest turnover ratio of 1.91, marking the point of lowest operational efficiency. The subsequent improvement in the turnover ratio throughout 2024 and 2026 aligns with the reduction in the average days inventory was held, suggesting a strategic adjustment to optimize stock levels and improve liquidity.

AI Ask an analyst for more


Average Receivable Collection Period

Medtronic PLC, average receivable collection period calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data
Receivables turnover 5.91 5.47 5.58 5.44 5.46 5.15 5.43 5.27 5.42 5.28 5.42 5.39 5.44 5.21 5.23 5.48 5.85 5.71 5.84 5.79 5.82
Short-term Activity Ratio (no. days)
Average receivable collection period1 62 67 65 67 67 71 67 69 67 69 67 68 67 70 70 67 62 64 63 63 63
Benchmarks (no. days)
Average Receivable Collection Period, Competitors2
Abbott Laboratories 67 66 65 68 67 63 60 62 61 60 60 59 56 53 52 52 58 59
Elevance Health Inc. 24 26 22 22 25 25 20 18 21 23 20 20 19 22 19 19 19 22
Intuitive Surgical Inc. 55 55 55 48 51 51 54 53 53 56 58 51 50 53 55 51 51 56
UnitedHealth Group Inc. 18 22 19 19 21 24 21 19 22 26 21 21 19 25 20 20 22 23

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 5.91 = 62

2 Click competitor name to see calculations.


An analysis of the operating activity ratios reveals a period of stability followed by a moderate increase in the time required to collect receivables, concluding with a return to historical efficiency levels by the end of the observed period.

Receivables Turnover Trends
The receivables turnover ratio remained relatively stable between 5.71 and 5.85 during the first year of analysis. A gradual decline was observed starting in late 2022, with the ratio reaching a low of 5.15 in January 2025. Following this trough, a recovery trend emerged, culminating in a peak turnover ratio of 5.91 by July 2026, representing the highest efficiency level recorded in the dataset.
Average Receivable Collection Period
The collection period began at 63 days and remained consistent until July 2022. A shift toward slower collections occurred in 2023, with the period extending to 70 days by January and April of that year. The collection period fluctuated between 67 and 69 days for several subsequent quarters, reaching a maximum of 71 days in January 2025. A notable improvement in collection speed occurred toward the end of the period, with the duration dropping to 62 days by July 2026.
Operational Efficiency Correlation
A consistent inverse correlation exists between the receivables turnover ratio and the average collection period. The period of lowest turnover between January 2023 and April 2024 corresponds directly with the increase in the collection period to 67-70 days. The efficiency peak in July 2026, characterized by a turnover ratio of 5.91, aligns with the minimum collection period of 62 days, indicating an optimization of the credit-to-cash cycle.

The overall trajectory indicates that while there was a multi-year period of decelerated receivable collections peaking in early 2025, the operational activity has since reverted to, and slightly improved upon, the efficiency levels observed at the start of the analysis period.

AI Ask an analyst for more


Operating Cycle

Medtronic PLC, operating cycle calculation (quarterly data)

No. days

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data
Average inventory processing period 173 171 185 187 181 172 178 173 174 170 187 190 191 180 190 183 174 166 161 153 148
Average receivable collection period 62 67 65 67 67 71 67 69 67 69 67 68 67 70 70 67 62 64 63 63 63
Short-term Activity Ratio
Operating cycle1 235 238 250 254 248 243 245 242 241 239 254 258 258 250 260 250 236 230 224 216 211
Benchmarks
Operating Cycle, Competitors2
Abbott Laboratories 199 195 188 195 201 193 181 198 197 198 193 194 195 185 170 160 171 168
Intuitive Surgical Inc. 256 254 251 249 250 249 254 261 254 249 244 234 216 215 216 206 190 186

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 173 + 62 = 235

2 Click competitor name to see calculations.


The operating cycle exhibits a general upward trend from mid-2021 through early 2023, followed by a period of relative stabilization with moderate volatility. The overall extension of the cycle is primarily driven by increases in inventory processing time rather than changes in receivable collection efficiency.

Average Inventory Processing Period
A significant expansion is observed in the time required to process inventory, rising from 148 days in July 2021 to a peak of 191 days in July 2023. Following this peak, the period fluctuates between 170 and 187 days. The most recent data indicates a slight stabilization around 173 days as of July 2026, though this remains substantially higher than the initial 2021 levels, suggesting a structural shift in inventory holding patterns.
Average Receivable Collection Period
The collection period demonstrates remarkable stability throughout the analyzed timeframe. Values remain within a narrow corridor, fluctuating between a minimum of 62 days and a maximum of 71 days. The consistency of this metric indicates that credit policies and collection efficiencies have remained constant regardless of the volatility seen in other components of the operating cycle.
Operating Cycle Synthesis
The total operating cycle increased from 211 days in July 2021 to a peak of 260 days in January 2023. Because the receivable collection period remained flat, the 49-day expansion observed during the growth phase is attributable almost exclusively to the average inventory processing period. In the final quarters of the analysis, the cycle shows a moderate contraction, ending at 235 days in July 2026, reflecting a slight improvement in inventory turnover relative to the 2023 peaks.

AI Ask an analyst for more


Average Payables Payment Period

Medtronic PLC, average payables payment period calculation (quarterly data)

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data
Payables turnover 4.87 4.81 4.85 4.64 4.65 4.75 5.04 4.85 4.95 4.65 5.60 5.09 4.84 4.03 4.68 4.60 4.62 4.46 5.14 5.41 5.67
Short-term Activity Ratio (no. days)
Average payables payment period1 75 76 75 79 79 77 72 75 74 78 65 72 75 91 78 79 79 82 71 67 64
Benchmarks (no. days)
Average Payables Payment Period, Competitors2
Abbott Laboratories 87 87 80 78 83 82 82 80 83 84 87 80 85 82 88 78 86 91
Elevance Health Inc. 45 45 42 44 45 46 45 45 45 48 47 48 48 48 49 49 50 50
Intuitive Surgical Inc. 28 34 27 33 32 35 26 31 28 29 29 31 33 28 26 30 29 25
UnitedHealth Group Inc. 46 46 46 49 49 50 47 48 47 50 49 51 52 53 50 52 53 54

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 4.87 = 75

2 Click competitor name to see calculations.


The analysis of short-term operating activity reveals a period of volatility in the management of accounts payable between mid-2021 and early 2024, followed by a phase of relative stability in the payment cycle.

Payables Turnover Trends
A gradual decline in the turnover ratio was observed from a high of 5.67 in July 2021 to a minimum of 4.03 in April 2023. This downward trend indicates a reduction in the frequency with which supplier obligations were settled. Following this trough, the ratio recovered and maintained a consistent range between 4.64 and 4.87 from July 2024 through July 2026, suggesting a stabilized operational cadence.
Average Payables Payment Period
The payment period exhibited a significant expansion during the first two years of the period, rising from 64 days in July 2021 to a peak of 91 days in April 2023. A sharp correction occurred thereafter, with the period dropping to 65 days by January 2024. Since mid-2024, the payment duration has normalized, fluctuating narrowly between 72 and 79 days, indicating a consistent approach to liability management.
Working Capital Implications
The expansion of the payment period up to 91 days suggests a period of aggressive working capital optimization, where the extension of payment terms served to preserve cash liquidity. The subsequent stabilization around the 75-day mark indicates a shift toward a sustainable equilibrium between liquidity preservation and the maintenance of supplier relationships.

AI Ask an analyst for more


Cash Conversion Cycle

Medtronic PLC, cash conversion cycle calculation (quarterly data)

No. days

Microsoft Excel
Jul 31, 2026 Apr 24, 2026 Jan 23, 2026 Oct 24, 2025 Jul 25, 2025 Apr 25, 2025 Jan 24, 2025 Oct 25, 2024 Jul 26, 2024 Apr 26, 2024 Jan 26, 2024 Oct 27, 2023 Jul 28, 2023 Apr 28, 2023 Jan 27, 2023 Oct 28, 2022 Jul 29, 2022 Apr 29, 2022 Jan 28, 2022 Oct 29, 2021 Jul 30, 2021
Selected Financial Data
Average inventory processing period 173 171 185 187 181 172 178 173 174 170 187 190 191 180 190 183 174 166 161 153 148
Average receivable collection period 62 67 65 67 67 71 67 69 67 69 67 68 67 70 70 67 62 64 63 63 63
Average payables payment period 75 76 75 79 79 77 72 75 74 78 65 72 75 91 78 79 79 82 71 67 64
Short-term Activity Ratio
Cash conversion cycle1 160 162 175 175 169 166 173 167 167 161 189 186 183 159 182 171 157 148 153 149 147
Benchmarks
Cash Conversion Cycle, Competitors2
Abbott Laboratories 112 108 108 117 118 111 99 118 114 114 106 114 110 103 82 82 85 77
Intuitive Surgical Inc. 228 220 224 216 218 214 228 230 226 220 215 203 183 187 190 176 161 161

Based on: 10-Q (reporting date: 2026-07-31), 10-K (reporting date: 2026-04-24), 10-Q (reporting date: 2026-01-23), 10-Q (reporting date: 2025-10-24), 10-Q (reporting date: 2025-07-25), 10-K (reporting date: 2025-04-25), 10-Q (reporting date: 2025-01-24), 10-Q (reporting date: 2024-10-25), 10-Q (reporting date: 2024-07-26), 10-K (reporting date: 2024-04-26), 10-Q (reporting date: 2024-01-26), 10-Q (reporting date: 2023-10-27), 10-Q (reporting date: 2023-07-28), 10-K (reporting date: 2023-04-28), 10-Q (reporting date: 2023-01-27), 10-Q (reporting date: 2022-10-28), 10-Q (reporting date: 2022-07-29), 10-K (reporting date: 2022-04-29), 10-Q (reporting date: 2022-01-28), 10-Q (reporting date: 2021-10-29), 10-Q (reporting date: 2021-07-30).

1 Q1 2027 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 173 + 6275 = 160

2 Click competitor name to see calculations.


The cash conversion cycle exhibits a general upward trend from July 2021 through early 2024, indicating a lengthening of the time required to convert resource inputs into cash flows. This increase is primarily driven by a significant extension in the inventory processing period, which was partially offset by an extension in payables payment terms. Following a peak in January 2024, the cycle has shown a moderate trend toward stabilization and slight reduction.

Average Inventory Processing Period
A sustained increase is observed from July 2021, where the period stood at 148 days, peaking at 191 days in July 2023. This indicates a slowing of inventory turnover during this phase. Subsequently, the period experienced a correction, dropping to 170 days by April 2024, before stabilizing between 171 and 187 days through July 2026.
Average Receivable Collection Period
The collection of receivables remained remarkably stable throughout the analyzed period. The duration fluctuated within a narrow range of 62 to 71 days, suggesting consistent credit policies and efficient collection processes that were not significantly impacted by the volatility seen in other components of the working capital cycle.
Average Payables Payment Period
Payment terms to suppliers were extended from 64 days in July 2021 to a peak of 91 days in April 2023. This extension served as a strategic buffer to mitigate the cash flow pressure caused by rising inventory levels. In the latter half of the period, the payment period normalized, fluctuating between 65 and 79 days.
Cash Conversion Cycle
The overall cash conversion cycle rose from 147 days in July 2021 to a maximum of 189 days in January 2024. The expansion was almost entirely attributable to the increase in the inventory processing period. A reduction is noted starting in April 2024, with the cycle closing at 160 days in July 2026, representing a partial recovery in operational efficiency compared to the 2023-2024 peak, though remaining higher than the 2021 baseline.

AI Ask an analyst for more